{"nct_id":"NCT03158688","title":"Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2017-06-13","start_date_type":"ACTUAL","primary_completion_date":"2019-07-14","primary_completion_date_type":"ACTUAL","completion_date":"2022-04-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}